AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35399845 — intervention group
Group type: COMPARATOR
Intervention: Meloxicam (CG)
Number of subjects: 81
Study 35399845 — intervention group
Group type: COMPARATOR
Intervention: Warm acupuncture (TCMG)
Number of subjects: 81
Study 35399845 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (JG, CG, TCMG)
Number of subjects: 81
Study 35399845 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement time of clinical symptoms (JG, CG, TCMG)
Number of subjects: 81
Study 34265850 — intervention group
Group type: EXPERIMENTAL
Intervention: Music training
Number of subjects: 123
Study 34265850 — intervention group
Group type: EXPERIMENTAL
Intervention: Foreign language training
Number of subjects: 123
Study 34265850 — intervention group
Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 123
Study 35760423 — intervention group
Group type: EXPERIMENTAL
Intervention: User centered clinical decision support tool
Number of subjects: 5047
Study 35760423 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5047
Study 32347137 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) algorithm with linear kernel function applied to training data
Number of subjects: 210
Study 32347137 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) algorithm with linear kernel function applied to test set
Number of subjects: 210
Study 36037286 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed medial arch support A
Number of subjects: 12
Study 36037286 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed medial arch support B
Number of subjects: 12
Study 36037286 — intervention group
Group type: COMPARATOR
Intervention: Prefabricated arch support C
Number of subjects: 12
Study 33358162 — intervention group
Group type: EXPERIMENTAL
Intervention: Filter bags (F57)
Number of subjects: 18
Study 33358162 — intervention group
Group type: COMPARATOR
Intervention: Loose powder (LS)
Number of subjects: 18
Study 32004568 — intervention group
Group type: EXPERIMENTAL
Intervention: Bermekimab (400 mg weekly for 13 doses) in anti-TNF naïve patients (n = 18)
Number of subjects: 42
Study 32004568 — intervention group
Group type: EXPERIMENTAL
Intervention: Bermekimab (400 mg weekly for 13 doses) in patients who failed anti-TNF therapy (n = 24)
Number of subjects: 42
Study 35580634 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral phenazopyridine (200 mg taken 1 to 2 hours preprocedure)
Number of subjects: 100
Study 35580634 — intervention group
Group type: COMPARATOR
Intervention: Intravesical lidocaine (20-minute instillation of 50 mL of 2% lidocaine)
Number of subjects: 100
Study 35580634 — intervention group
Group type: COMPARATOR
Intervention: Provider perception of participant comfort and overall ease of procedure
Number of subjects: 100
Study 35580634 — intervention group
Group type: COMPARATOR
Intervention: Length of time in the exam room
Number of subjects: 100
Study 35580634 — intervention group
Group type: COMPARATOR
Intervention: Cystoscopic visualization
Number of subjects: 100
Study 32255549 — intervention group
Group type: EXPERIMENTAL
Intervention: MW01-6-189WH (MW189)
Number of subjects: 100
Study 32255549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32141476 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar mobile Application (Bip.App)
Number of subjects: 0
Study 32141476 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Psychoeducation (PE)
Number of subjects: 0
Study 32141476 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Bip.App and Group PE
Number of subjects: 0
Study 32141476 — intervention group
Group type: EXPERIMENTAL
Intervention: Bip.App
Number of subjects: 0
Study 35421984 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal balloon autoinflation
Number of subjects: 340
Study 35421984 — intervention group
Group type: COMPARATOR
Intervention: No nasal balloon autoinflation (Control)
Number of subjects: 340
Study 35317665 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 144
Study 35317665 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 144
Study 35317665 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 144
Study 32873287 — intervention group
Group type: EXPERIMENTAL
Intervention: UNICEF/Washington Group Child Functioning Module (CFM)
Number of subjects: 1439
Study 32873287 — intervention group
Group type: COMPARATOR
Intervention: Modified Washington Group short set (mWG-SS)
Number of subjects: 1439
Study 35802142 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg OD
Number of subjects: 140
Study 35802142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 33588084 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy dietary pattern
Number of subjects: 392
Study 33588084 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean dietary pattern
Number of subjects: 392
Study 33588084 — intervention group
Group type: EXPERIMENTAL
Intervention: Western dietary pattern
Number of subjects: 392
Study 33588084 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable dietary pattern
Number of subjects: 392
Study 33036201 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed whey infant formula (PHF)
Number of subjects: 142
Study 33036201 — intervention group
Group type: COMPARATOR
Intervention: Standard infant formula with intact protein (IPF)
Number of subjects: 142
Study 34052908 — intervention group
Group type: EXPERIMENTAL
Intervention: SSGT KONTAKT® (n = 46)
Number of subjects: 90
Study 34052908 — intervention group
Group type: COMPARATOR
Intervention: Active control (manualised interactive group cooking programme, n = 44)
Number of subjects: 90
Study 34052908 — intervention group
Group type: EXPERIMENTAL
Intervention: SSGT KONTAKT®
Number of subjects: 90
Study 33827421 — intervention group
Group type: COMPARATOR
Intervention: Sodium valproate (group A)
Number of subjects: 222
Study 33827421 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent magnesium with sodium valproate (group B)
Number of subjects: 222
Study 33827421 — intervention group
Group type: COMPARATOR
Intervention: Magnesium (group C)
Number of subjects: 222
Study 36038015 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (0.2 mg nicotine/cigarette)
Number of subjects: 0
Study 36038015 — intervention group
Group type: COMPARATOR
Intervention: Usual Nicotine Content (UNC) cigarettes (11.6 mg nicotine/cigarette)
Number of subjects: 0
Study 36038015 — intervention group
Group type: EXPERIMENTAL
Intervention: VLNC cigarettes in the gradual nicotine reduction arm for non-menthol smokers
Number of subjects: 0
Study 34883808 — intervention group
Group type: EXPERIMENTAL
Intervention: ICAGD coronoplasty
Number of subjects: 100
Study 34883808 — intervention group
Group type: COMPARATOR
Intervention: Tooth polishing
Number of subjects: 100
Study 35759325 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic adherence and competence scale for grief (TACs-G)
Number of subjects: 48
Study 32365981 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299v with 20 mg of iron
Number of subjects: 53
Study 32365981 — intervention group
Group type: COMPARATOR
Intervention: 20 mg of iron alone
Number of subjects: 53
Study 35410241 — intervention group
Group type: EXPERIMENTAL
Intervention: mySugr PRO (digital self-management application)
Number of subjects: 466
Study 35410241 — intervention group
Group type: COMPARATOR
Intervention: Control group (no usage of the application)
Number of subjects: 466
Study 34078314 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab plus bortezomib/melphalan/prednisone (D-VMP)
Number of subjects: 0
Study 34078314 — intervention group
Group type: COMPARATOR
Intervention: VMP alone
Number of subjects: 0
Study 32389050 — intervention group
Group type: EXPERIMENTAL
Intervention: Precontoured lateral locking plate fixation with interfragmentary lag screws
Number of subjects: 76
Study 32389050 — intervention group
Group type: COMPARATOR
Intervention: Precontoured lateral locking plate fixation without interfragmentary lag screws
Number of subjects: 76
Study 32389050 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (with and without lag screws)
Number of subjects: 76
Study 35761383 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg per os 2 hours before surgery
Number of subjects: 144
Study 35761383 — intervention group
Group type: COMPARATOR
Intervention: Starch tablet per os 2 hours before surgery (control group)
Number of subjects: 144
Study 34011111 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention
Number of subjects: 140
Study 34011111 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 140
Study 32197636 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunct low-dose continuous infusion of ketamine (2 μg/kg/min for the first 24 hours, then 1 μg/kg/min for the second 24 hours) plus standard of care.
Number of subjects: 80
Study 32197636 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (propofol and/or fentanyl and/or midazolam) according to the KFSH&RC sedation and analgesia protocol.
Number of subjects: 80
Study 36134443 — intervention group
Group type: EXPERIMENTAL
Intervention: App-guided fluid therapy calculations
Number of subjects: 55
Study 36134443 — intervention group
Group type: EXPERIMENTAL
Intervention: App-guided integrated fluid therapy plans
Number of subjects: 55
Study 36134443 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 55
Study 36134443 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for app-guided method
Number of subjects: 55
Study 32858228 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D 2000 IU/day
Number of subjects: 2157
Study 32858228 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids 1000 mg/day (EPA+DHA, ratio 1:2)
Number of subjects: 2157
Study 32858228 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute home exercise 3 times/week (strength versus flexibility)
Number of subjects: 2157
Study 32858228 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 2157
Study 35614848 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary carbohydrate intake
Number of subjects: 547
Study 35614848 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fibre and glycaemic index
Number of subjects: 547
Study 32014055 — intervention group
Group type: EXPERIMENTAL
Intervention: hUC‐MSC transplantation (four transfusions intravenously)
Number of subjects: 39
Study 32014055 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 39
Study 32014055 — intervention group
Group type: EXPERIMENTAL
Intervention: hUC‐MSC transplantation
Number of subjects: 39
Study 33201154 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal sleeve (NS)
Number of subjects: 15
Study 33201154 — intervention group
Group type: EXPERIMENTAL
Intervention: Tighter sleeve (TS)
Number of subjects: 15
Study 33201154 — intervention group
Group type: COMPARATOR
Intervention: Control sleeve (CS)
Number of subjects: 15
Study 32527389 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol dose of .04 g/dl
Number of subjects: 184
Study 32527389 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol dose of .065 g/dl
Number of subjects: 184
Study 32527389 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol doses (.04 g/dl and .065 g/dl)
Number of subjects: 184
Study 34303355 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial of labor after cesarean section (TOLAC)
Number of subjects: 778
Study 34303355 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram prediction model based on multiple logistic regression analysis
Number of subjects: 778
Study 34303355 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with successful TOLAC
Number of subjects: 778
Study 33317481 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy
Number of subjects: 187
Study 33317481 — intervention group
Group type: EXPERIMENTAL
Intervention: Health qigong-based cognitive therapy
Number of subjects: 187
Study 33317481 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 187
Study 37393402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg (with 300 mg loading dose) for 24 weeks
Number of subjects: 457
Study 37393402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg (with 300 mg loading dose) for 12 weeks then bepirovirsen 150 mg for 12 weeks
Number of subjects: 457
Study 37393402 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg (with 300 mg loading dose) for 12 weeks then placebo for 12 weeks
Number of subjects: 457
Study 37393402 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo for 12 weeks (with placebo loading dose) then bepirovirsen 300 mg without loading dose for 12 weeks
Number of subjects: 457
Study 34429312 — intervention group
Group type: EXPERIMENTAL
Intervention: QLBA (anterior quadratus lumborum block at the lateral supra-arcuate ligament)
Number of subjects: 100
Study 34429312 — intervention group
Group type: COMPARATOR
Intervention: QLB2 (posterior quadratus lumborum block)
Number of subjects: 100
Study 34429312 — intervention group
Group type: EXPERIMENTAL
Intervention: QLBA
Number of subjects: 100
Study 34429312 — intervention group
Group type: COMPARATOR
Intervention: QLB2
Number of subjects: 100
Study 32957397 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative nursing visit (experiential group)
Number of subjects: 200
Study 32957397 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative nursing visit)
Number of subjects: 200
Study 86099028 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine and prednisone (low-dose combination therapy)
Number of subjects: 25
Study 86099028 — intervention group
Group type: COMPARATOR
Intervention: D-penicillamine alone
Number of subjects: 25
Study 86099028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 32091466 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily nonlinear periodization (NLP)
Number of subjects: 58
Study 32091466 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible daily nonlinear periodization (FNLP)
Number of subjects: 58
Study 32091466 — intervention group
Group type: COMPARATOR
Intervention: Nonperiodization (NP)
Number of subjects: 58
Study 33566465 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin started less than 24 hours after insertion of central venous catheter, adjusted to anti-Xa level of 0.2–0.5 international units/mL
Number of subjects: 51
Study 33566465 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 51
Study 35525503 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium Laser En‐bloc Resection of Bladder Tumors (HoLERBT)
Number of subjects: 8
Study 35525503 — intervention group
Group type: COMPARATOR
Intervention: Transurethral Resection of Bladder Tumor (TURBT)
Number of subjects: 8
Study 36286503 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training intervention with music
Number of subjects: 0
Study 34293156 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week advocacy program
Number of subjects: 50
Study 34293156 — intervention group
Group type: COMPARATOR
Intervention: Physical activity (PA) comparison intervention
Number of subjects: 50
Study 32169923 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised self-management kits
Number of subjects: 308
Study 32169923 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment (Control)
Number of subjects: 308
Study 32169923 — intervention group
Group type: COMPARATOR
Intervention: Standardised self-management kits and Usual treatment (Control)
Number of subjects: 308
Study 34348522 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking on a treadmill during the post-test phase
Number of subjects: 36
Study 34348522 — intervention group
Group type: COMPARATOR
Intervention: Sitting during the post-test phase
Number of subjects: 36
Study 32960464 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐MEDSS with usual care HMR
Number of subjects: 201
Study 32960464 — intervention group
Group type: COMPARATOR
Intervention: Usual care HMR alone
Number of subjects: 201
Study 32574657 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) intervention (four sessions)
Number of subjects: 60
Study 32574657 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 60
Study 35183180 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MAP-I)
Number of subjects: 0
Study 35183180 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 0
Study 32909309 — intervention group
Group type: EXPERIMENTAL
Intervention: On-road driving rehabilitation program (immediate intervention)
Number of subjects: 8
Study 32909309 — intervention group
Group type: COMPARATOR
Intervention: Wait-list group (6 weeks delay)
Number of subjects: 8
Study 32909309 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall participants (both groups)
Number of subjects: 8
Study 32557974 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM sublingual immunotherapy (SLIT)
Number of subjects: 112
Study 32557974 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy alone
Number of subjects: 112
Study 34464386 — intervention group
Group type: EXPERIMENTAL
Intervention: Online teaching after COVID-19 lockdown
Number of subjects: 79
Study 33444192 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 min passive work breaks including rest
Number of subjects: 21
Study 33444192 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 min active work breaks including mobility and stretching exercises
Number of subjects: 21
Study 33444192 — intervention group
Group type: COMPARATOR
Intervention: No work breaks
Number of subjects: 21
Study 35173164 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant trastuzumab emtansine (T-DM1)
Number of subjects: 100
Study 35173164 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant paclitaxel with trastuzumab (TH)
Number of subjects: 100
Study 33346013 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Review (NR)
Number of subjects: 111
Study 33346013 — intervention group
Group type: COMPARATOR
Intervention: Systematic Review (SR)
Number of subjects: 111
Study 33970719 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified lottery for research funding allocation
Number of subjects: 0
Study 33970719 — intervention group
Group type: COMPARATOR
Intervention: Peer review system for research funding allocation
Number of subjects: 0
Study 34245960 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete wound drain removal 3 weeks after surgery
Number of subjects: 99
Study 34245960 — intervention group
Group type: COMPARATOR
Intervention: Progressive drain removal
Number of subjects: 99
Study 34245960 — intervention group
Group type: EXPERIMENTAL
Intervention: ILND
Number of subjects: 99
Study 33208575 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐purpose with silane contamination after-etching
Number of subjects: 160
Study 33208575 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐purpose with silane contamination after-priming
Number of subjects: 160
Study 33208575 — intervention group
Group type: EXPERIMENTAL
Intervention: Optibond FL with silane contamination after-etching
Number of subjects: 160
Study 33208575 — intervention group
Group type: EXPERIMENTAL
Intervention: Optibond FL with silane contamination after-priming
Number of subjects: 160
Study 33208575 — intervention group
Group type: COMPARATOR
Intervention: Scotchbond Multi‐purpose without silane contamination
Number of subjects: 160
Study 33208575 — intervention group
Group type: COMPARATOR
Intervention: Optibond FL without silane contamination
Number of subjects: 160
Study 34379802 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralymphatic immunotherapy (ILIT) with up-dosage of 1000-3000-10,000 SQ-U (5000 + 5000 with 30 minutes apart)
Number of subjects: 68
Study 34379802 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralymphatic immunotherapy (ILIT) with modified up-dosing schedule of 1000-3000-3000 SQ-U
Number of subjects: 68
Study 34379802 — intervention group
Group type: COMPARATOR
Intervention: Intralymphatic immunotherapy (ILIT)
Number of subjects: 68
Study 34022336 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive-test participants
Number of subjects: 840
Study 34022336 — intervention group
Group type: COMPARATOR
Intervention: Negative-test participants
Number of subjects: 840
Study 32036610 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed HDF
Number of subjects: 120
Study 32036610 — intervention group
Group type: COMPARATOR
Intervention: Post-HDF
Number of subjects: 120
Study 32036610 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed HDF vs Post-HDF
Number of subjects: 120
Study 35749343 — intervention group
Group type: EXPERIMENTAL
Intervention: Power to Quit (PTQ) program
Number of subjects: 315
Study 33832089 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD medical treatment + KT (Group 1)
Number of subjects: 0
Study 33832089 — intervention group
Group type: COMPARATOR
Intervention: COPD medical treatment alone (Group 2)
Number of subjects: 0
Study 32376313 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of an intrauterine device (IUD) with a Foley catheter after hysteroscopic adhesiolysis
Number of subjects: 118
Study 32376313 — intervention group
Group type: COMPARATOR
Intervention: Balloon uterine stent insertion after hysteroscopic adhesiolysis
Number of subjects: 118
Study 32376313 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IUD + Foley catheter and balloon uterine stent)
Number of subjects: 118
Study 34275789 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with citrate sufentanil
Number of subjects: 70
Study 34275789 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 70
Study 34955257 — intervention group
Group type: EXPERIMENTAL
Intervention: Low compound probiotics (0.12 g per head per day)
Number of subjects: 48
Study 34955257 — intervention group
Group type: EXPERIMENTAL
Intervention: High compound probiotics (1.2 g per head per day)
Number of subjects: 48
Study 34955257 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound probiotics (both low and high)
Number of subjects: 48
Study 34955257 — intervention group
Group type: COMPARATOR
Intervention: Control group (milk replacer with no compound probiotics)
Number of subjects: 48
Study 32686755 — intervention group
Group type: EXPERIMENTAL
Intervention: Embrace Nest Infant Warmer
Number of subjects: 120